The American Journal of Managed Care: Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments Tyler Morning Telegraph: Christus Health among first for trial treatment of atrial fibrillation CBS News: Results from University of Miami study could one day change how people with atrial fibrillation are treated Miller School of Medicine could one day change the way people with atrial fibrillation are treated. Researchers at UM conducted the Liraglutide Effects in Atrial Fibrillation (LEAF) study starting in ... Results from University of Miami study could one day change how people with atrial fibrillation are treated Atrial fibrillation treatment with device closure matched anticoagulants and reduced bleeding risk.
Discover what this means for AF care. Milwaukee Journal Sentinel: NovaRhythm Obtains Global Rights from Sanofi for SAR-297871 to Advance Precision Atrial Fibrillation Therapy NovaRhythm Obtains Global Rights from Sanofi for SAR-297871 to Advance Precision Atrial Fibrillation Therapy LUBBOCK, TX (NEWS RELEASE) - Covenant Health is excited to announce the introduction of Pulse Field Ablation (PFA) for the treatment of atrial fibrillation (A.Fib) at Covenant Medical Center (CMC). Kaleido Scope: Vardas co-authors clinical practice guidelines on surgical treatment for atrial fibrillation Tyler Morning Telegraph: Christus offers revolutionary atrial fibrillation treatment thanks to generosity of Hall family Christus Trinity Mother Frances Louis Peaches Owen Heart Hospital is one of the first hospitals in the country to institute a new, revolutionary, FDA-approved treatment for atrial fibrillation (AF), ... Christus offers revolutionary atrial fibrillation treatment thanks to generosity of Hall family The Business Journals: New treatment option for advanced atrial fibrillation patients in West Tennessee To continue reading this content, please enable JavaScript in your browser settings and refresh this page.
